---
title: "AIM ImmunoTech (AIM.US) — 财务报表"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/AIM.US/norm.md"
symbol: "AIM.US"
name: "AIM ImmunoTech"
parent: "https://longbridge.com/zh-CN/quote/AIM.US.md"
datetime: "2026-05-19T14:08:49.479Z"
locales:
  - [en](https://longbridge.com/en/quote/AIM.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/AIM.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/AIM.US/norm.md)
---

# AIM ImmunoTech (AIM.US) — 财务报表

## 利润表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | -0.6947 | -1.45 | -1.57 | -3.68 | -5.26 |
| ROE | 315.80% | 210.59% | 208.13% | 214.86% | 572.31% |
| 营业收入 | 22000.00 | 21000.00 | 26000.00 | 25000.00 | 16000.00 |
| 净利润 | -3.02M | -4.17M | -3.28M | -2.79M | -3.71M |
| 营业利润 | -2.23M | -2.95M | -2.45M | -2.65M | -3.62M |
| 毛利率 | 81.82% | -90.48% | -161.54% | 60.00% | 37.50% |
| 净利率 | -13740.91% | -19880.95% | -12630.77% | -11176.00% | -23156.25% |
| 利润含金量 | - | - | - | - | - |

## 资产负债表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 资产与负债 | 8.59M | 5.78M | 5.49M | 4.13M | 6.25M |
| 权益乘数 | 4.04 | -0.5910 | -0.9041 | -0.6308 | -1.62 |
| 每股净资产 | 0.2584 | -3.19 | -2.20 | -8.56 | -5.33 |
| 资产周转率 | 0.0127 | 0.0122 | 0.0117 | 0.0122 | 0.0130 |
| 现金及短投 | 5.88M | 3.05M | 2.41M | 835000.00 | 2.25M |
| 存货与应收 | - | - | - | - | - |
| 长期投资 | 382000.00 | 449000.00 | 516000.00 | 585000.00 | 652000.00 |
| 净债务 | -1.30M | 1.85M | -71000.00 | 1.97M | 275000.00 |

## 现金流量表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 经营现金流 | -2.72M | -1.99M | -5.08M | -1.53M | -2.36M |
| 投资现金流 | -37000.00 | -95000.00 | 296000.00 | 754000.00 | 898000.00 |
| 融资现金流 | 5.59M | 2.72M | 6.65M | 355000.00 | 660000.00 |
| 自由现金流 | -2.01M | -1.49M | -7.39M | -1.39M | -1.74M |
| 现金流充裕率 | -1359.50% | - | -769.55% | - | - |
| 举债与偿债 | - | 2.50M | 0.0000 | 250000.00 | - |
| 资本支出 | - | - | - | - | - |